Tải bản đầy đủ - 0trang
TÀI LIỆU THAM KHẢO
Alberti, K., et al., Harmonizing the metabolic syndrome: a joint interim
statement of the international diabetes federation task force on
epidemiology and prevention; national heart, lung, and blood institute;
American heart association; world heart federation; international
atherosclerosis society; and international association for the study of
obesity. Circulation, 2009. 120(16): p. 1640-1645.
thrombosis, and vascular biology, 2008. 28(4): p. 629-636.
Ford, E.S., W.H. Giles, and W.H. Dietz, Prevalence of the metabolic
syndrome among US adults: findings from the third National Health and
Nutrition Examination Survey. Jama, 2002. 287(3): p. 356-359.
Aguilar, M., et al., Prevalence of the metabolic syndrome in the United
States, 2003-2012. Jama, 2015. 313(19): p. 1973-1974.
Pan, W.-H., W.-T. Yeh, and L.-C. Weng, Epidemiology of metabolic
syndrome in Asia. Asia Pacific journal of clinical nutrition, 2008. 17(S1):
Van Tran, H., M. T Truong, and T. Nguyen, Prevalence of Metabolic
Syndrome in Adults in Khanh Hoa, Vietnam. Vol. 1. 2004. 95-100.
Binh, T., et al., Metabolic syndrome among a middle-aged population in
the Red River Delta region of Vietnam. Vol. 14. 2014. 77.
Chan, J.C., et al., Diabetes in Asia: epidemiology, risk factors, and
pathophysiology. Jama, 2009. 301(20): p. 2129-2140.
Lin, C.-C., et al., The relation of metabolic syndrome according to five
definitions to cardiovascular risk factors-a population-based study.
BMC Public Health, 2009. 9(1): p. 484.
10. Crepaldi, G. and S. Maggi, The metabolic syndrome: a historical
context. Diabetes voice, 2006. 51: p. 8-10.
11. Sarafidis, P.A. and P.M. Nilsson, The metabolic syndrome: a glance at
its history. Journal of hypertension, 2006. 24(4): p. 621-626.
12. Expert Panel on Detection, E., Executive summary of the Third Report of
the National Cholesterol Education Program (NCEP) expert panel on
detection, evaluation, and treatment of high blood cholesterol in adults
(Adult Treatment Panel III). Jama, 2001. 285(19): p. 2486.
13. Bravata, D.M., et al., Two measures of insulin sensitivity provided
similar information in a US population. Journal of clinical epidemiology,
2004. 57(11): p. 1214-1217.
14. Carey, D.G., et al., Abdominal fat and insulin resistance in normal and
overweight women: direct measurements reveal a strong relationship in
subjects at both low and high risk of NIDDM. Diabetes, 1996. 45(5): p.
15. Bacon, B., Harrison's Principles of Internal Medicine. 19e. 2015, New
York, NY: McGraw-Hill Education.
16. Flegal, K.M., et al., Trends in obesity among adults in the United States,
2005 to 2014. Jama, 2016. 315(21): p. 2284-2291.
17. Stefan, N., et al., Identification and characterization of metabolically
benign obesity in humans. Archives of internal medicine, 2008. 168(15):
18. Franỗa, S.L., S.S. Lima, and J.R.D.S. Vieira, Metabolic syndrome and
associated factors in adults of the Amazon region. PloS one, 2016.
11(12): p. e0167320.
19. Zhao, Y., et al., Prevalence and determinants of metabolic syndrome
among adults in a rural area of Northwest China. PloS one, 2014. 9(3):
20. Chan, J.M., et al., Obesity, fat distribution, and weight gain as risk factors
for clinical diabetes in men. Diabetes care, 1994. 17(9): p. 961-969.
21. Stamler, J., Epidemiologic findings on body mass and blood pressure in
adults. Annals of epidemiology, 1991. 1(4): p. 347-362.
22. Force, U.P.S.T., Screening for obesity in adults: recommendations and
rationale. Annals of internal medicine, 2003. 139(11): p. 930.
23. Kannel, W. and D. McGee, Diabetes and glucose tolerance as risk
factors for cardiovascular disease: the Framingham study. Diabetes
care, 1979. 2(2): p. 120-126.
24. Reeder, B.A., et al., The association of cardiovascular disease risk
factors with abdominal obesity in Canada. Canadian Heart Health
Surveys Research Group. CMAJ: Canadian Medical Association journal
journal de l'Association medicale canadienne, 1997. 157: p. S39-45.
25. Kenchaiah, S., et al., Obesity and the risk of heart failure. New England
Journal of Medicine, 2002. 347(5): p. 305-313.
26. Tokunaga, K., et al., A novel technique for the determination of body fat
by computed tomography. International journal of obesity, 1983. 7(5): p.
27. Fujioka, S., et al., Contribution of intra-abdominal fat accumulation to
the impairment of glucose and lipid metabolism in human obesity.
Metabolism, 1987. 36(1): p. 54-59.
28. Rexrode, K.M., et al., Abdominal adiposity and coronary heart disease
in women. Jama, 1998. 280(21): p. 1843-1848.
29. Després, J.-P., et al., Estimation of deep abdominal adipose-tissue
accumulation from simple anthropometric measurements in men. The
American journal of clinical nutrition, 1991. 54(3): p. 471-477.
30. Ferland, M., et al., Assessment of adipose tissue distribution by
computed axial tomography in obese women: association with body
density and anthropometric measurements. British Journal of Nutrition,
1989. 61(2): p. 139-148.
31. Dalton, M., et al., Waist circumference, waist–hip ratio and body mass
index and their correlation with cardiovascular disease risk factors in
Australian adults. Journal of internal medicine, 2003. 254(6): p. 555-563.
32. Kershaw, E.E. and J.S. Flier, Adipose tissue as an endocrine organ. The
Journal of Clinical Endocrinology & Metabolism, 2004. 89(6): p. 2548-2556.
33. Tilg, H. and A.R. Moschen, Role of adiponectin and PBEF/visfatin as
regulators of inflammation: involvement in obesity-associated diseases.
Clinical science, 2008. 114(4): p. 275-288.
34. Randle, P., P. Garland, and C. HALr, s & EA NEWSHOLME. 1963. The
glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic
disturbances of diabetes mellitus. Lancet i: p. 785-789.
35. Weisberg, S.P., et al., Obesity is associated with macrophage
accumulation in adipose tissue. Journal of clinical investigation, 2003.
112(12): p. 1796.
36. Ginsberg, H.N., Y.-L. Zhang, and A. Hernandez-Ono, Regulation of
plasma triglycerides in insulin resistance and diabetes. Archives of
medical research, 2005. 36(3): p. 232-240.
37. Alberti, K.G.M.M. and P.f. Zimmet, Definition, diagnosis and
classification of diabetes mellitus and its complications. Part 1:
diagnosis and classification of diabetes mellitus. Provisional report of a
WHO consultation. Diabetic medicine, 1998. 15(7): p. 539-553.
38. Balkau, B., Comment on the provisional report from the WHO
consultation. European Group for the Study of Insulin Resistance
(EGIR). Diabet Med, 1999. 16: p. 442-443.
39. Expert Panel on, D., Evaluation, and A. and Treatment of High Blood
Cholesterol in, Executive summary of the third report of the national
cholesterol education program (ncep) expert panel on detection,
evaluation, and treatment of high blood cholesterol in adults (adult
treatment panel iii). JAMA, 2001. 285(19): p. 2486-2497.
40. Bloomgarden, Z.T., American Association of Clinical Endocrinologists
(AACE) consensus conference on the insulin resistance syndrome: 25–26
August 2002, Washington, DC. Diabetes Care, 2003. 26(3): p. 933-939.
41. Alberti, K.G.M.M., P. Zimmet, and J. Shaw, Metabolic syndrome—a
new world‐wide definition. A consensus statement from the international
diabetes federation. Diabetic medicine, 2006. 23(5): p. 469-480.
42. Binh, T.Q., P.T. Phuong, and B.T. Nhung, Metabolic syndrome among a
middle-aged population in the Red River Delta region of Vietnam. BMC
endocrine disorders, 2014. 14(1): p. 77.
43. Cornier, M.-A., et al., The metabolic syndrome. Endocrine reviews,
2008. 29(7): p. 777-822.
44. Kvist, H., et al., Total and visceral adipose-tissue volumes derived from
measurements with computed tomography in adult men and women:
predictive equations. The American journal of clinical nutrition, 1988.
48(6): p. 1351-1361.
45. Pradhan, A.D., Sex Differences in the Metabolic Syndrome: Implications
for Cardiovascular Health in Women. Clinical Chemistry, 2014. 60(1): p.
46. Duc Son LNT, K.D., Hung NT, Sakai T, Yamamoto S: The metabolic,
s.p.a.r.f.i.t.u.p.o.H. Chi, and Minh City. Diabet Res Clin Pract 2005.
47. Ford, E.S., Prevalence of the metabolic syndrome defined by the
International Diabetes Federation among adults in the US. Diabetes
care, 2005. 28(11): p. 2745-2749.
48. Lao, X.Q., et al., Dramatic escalation in metabolic syndrome and
cardiovascular risk in a Chinese population experiencing rapid
economic development. BMC Public Health, 2014. 14(1): p. 983.
49. Sy, R.G., et al., Socio-demographic factors and the prevalence of
metabolic syndrome among Filipinos from the LIFECARE cohort.
Journal of atherosclerosis and thrombosis, 2014. 21(Supplement1): p.
50. Van Tran, H., M. Truong, and T. Nguyen, Prevalence of metabolic
syndrome in adults in Khanh Hoa, Viet Nam. J Geriatr Cardiol, 2004.
1(2): p. 95-100.
51. Trương, T.M. and T.L. Nguyễn, Tình trạng kháng Insulin và hội chứng
rối loạn chuyển hóa ở người trưởng thành 40-59 tuổi thừa cân béo phì
tại một phường nội thành Hà Nội (Insulin resistance and metabolic
syndrome in overweight/obesity adults 40-59 years at a ward, Hanoi).
52. Palaniappan, L.P., et al., Asian Americans have greater prevalence of
metabolic syndrome despite lower body mass index. International journal
of obesity (2005), 2011. 35(3): p. 393.
53. Wamala, S.P., et al., Education and the metabolic syndrome in women.
Diabetes care, 1999. 22(12).
54. Silventoinen, K., et al., Educational inequalities in the metabolic
syndrome and coronary heart disease among middle-aged men and
women. International Journal of Epidemiology, 2005. 34(2): p. 327-334.
55. Brunner, E., et al., Social inequality in coronary risk: central obesity and
the metabolic syndrome. Evidence from the Whitehall II study.
Diabetologia, 1997. 40(11): p. 1341-1349.
56. Park, M.J., et al., A cross-sectional study of socioeconomic status and
the metabolic syndrome in Korean adults. Annals of epidemiology, 2007.
17(4): p. 320-326.
57. Hoffmann, I.S. and L.X. Cubeddu, Salt and the metabolic syndrome.
Nutrition, Metabolism and Cardiovascular Diseases, 2009. 19(2): p. 123128.
58. Sakurai, Y., et al., Relation of total and beverage-specific alcohol intake
to body mass index and waist-to-hip ratio: a study of self-defense
officials in Japan. European journal of epidemiology, 1997. 13(8): p.
59. General, S., J. Wright, and D.H. Speaker, Nicotine addiction. A report of
the Surgeon General. US Dept. of Health and Human Services,
Washington DC Google Scholar, 1988.
60. Wannamethee, S.G. and A.G. Shaper, Alcohol, body weight, and weight
gain in middle-aged men. The American journal of clinical nutrition,
2003. 77(5): p. 1312-1317.
61. GOUDE, D., B. FAGERBERG, and J. HULTHE, Alcohol consumption,
the metabolic syndrome and insulin resistance in 58-year-old clinically
healthy men (AIR study). Clinical Science, 2002. 102(3): p. 345-352.
62. Lazarus, R., D. Sparrow, and S.T. Weiss, Alcohol intake and insulin
levels: the Normative Aging Study. American journal of epidemiology,
1997. 145(10): p. 909-916.
63. Rimm, E.B., et al., Moderate alcohol intake and lower risk of coronary
heart disease: meta-analysis of effects on lipids and haemostatic factors.
Bmj, 1999. 319(7224): p. 1523-1528.
64. Fan, J.-G., et al., Alcohol consumption and metabolic syndrome among
Shanghai adults: a randomized multistage stratified cluster sampling
investigation. World Journal of Gastroenterology: WJG, 2008. 14(15): p. 2418.
65. McFadden, C.B., et al., Systematic review of the effect of daily alcohol
intake on blood pressure. 2005, Oxford University Press.
66. Xin, X., et al., Effects of alcohol reduction on blood pressure: a metaanalysis of randomized controlled trials. Hypertension, 2001. 38(5): p.
67. Slagter, S.N., et al., Combined effects of smoking and alcohol on metabolic
syndrome: the LifeLines cohort study. PloS one, 2014. 9(4): p. e96406.
68. Ambrose, J.A. and R.S. Barua, The pathophysiology of cigarette
smoking and cardiovascular disease: an update. Journal of the American
college of cardiology, 2004. 43(10): p. 1731-1737.
69. Xiao, J., et al., Prevalence of metabolic syndrome and its risk factors among
rural adults in Nantong, China. Scientific reports, 2016. 6: p. 38089.
70. Oh, S.W., et al., Association between cigarette smoking and metabolic
syndrome: the Korea National Health and Nutrition Examination
Survey. Diabetes care, 2005. 28(8): p. 2064-2066.
71. Zuo, H., et al., Prevalence of metabolic syndrome and factors associated
with its components in Chinese adults. Metabolism, 2009. 58(8): p.
72. Vona, M., et al., Impact of physical training and detraining on
endothelium-dependent vasodilation in patients with recent acute
myocardial infarction. American heart journal, 2004. 147(6): p. 1039-1046.
73. Boulé, N.G., et al., Effects of exercise on glycemic control and body
mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical
trials. Jama, 2001. 286(10): p. 1218-1227.
74. Ross, R., et al., Reduction in obesity and related comorbid conditions
after diet-induced weight loss or exercise-induced weight loss in men: a
randomized, controlled trial. Annals of internal medicine, 2000. 133(2):
75. Stensvold, D., et al., Strength training versus aerobic interval training to
modify risk factors of metabolic syndrome. Journal of applied
physiology, 2010. 108(4): p. 804-810.
76. Dunstan, D.W., et al., Effects of a short-term circuit weight training
program on glycaemic control in NIDDM. Diabetes research and clinical
practice, 1998. 40(1): p. 53-61.
77. Durstine, J.L., et al., Lipids, lipoproteins, and exercise. Journal of
Cardiopulmonary Rehabilitation and Prevention, 2002. 22(6): p. 385-398.
78. Moholdt, T.T., et al., Aerobic interval training versus continuous
moderate exercise after coronary artery bypass surgery: a randomized
study of cardiovascular effects and quality of life. American heart
journal, 2009. 158(6): p. 1031-1037.
79. Sigal, R.J., et al., Effects of aerobic training, resistance training, or both
on glycemic control in type 2 diabetes: a randomized trial. Annals of
internal medicine, 2007. 147(6): p. 357-369.
80. Kyu, H.H., et al., Physical activity and risk of breast cancer, colon
cancer, diabetes, ischemic heart disease, and ischemic stroke events:
systematic review and dose-response meta-analysis for the Global
Burden of Disease Study 2013. bmj, 2016. 354: p. i3857.
81. Albarwani D Phil, S., et al., Effects of overweight and leisure-time
activities on aerobic fitness in urban and rural adolescents. Metabolic
syndrome and related disorders, 2009. 7(4): p. 369-374.
82. Vandelanotte, C., et al., Associations of leisure-time internet and
computer use with overweight and obesity, physical activity and
sedentary behaviors: cross-sectional study. Journal of medical Internet
research, 2009. 11(3).
83. Gami, A.S., et al., Metabolic syndrome and risk of incident
cardiovascular events and death: a systematic review and meta-analysis
of longitudinal studies. Journal of the American College of Cardiology,
2007. 49(4): p. 403-414.
84. Mottillo, S., et al., The metabolic syndrome and cardiovascular risk: a
systematic review and meta-analysis. Journal of the American College of
Cardiology, 2010. 56(14): p. 1113-1132.
85. Lakka, H.-M., et al., The metabolic syndrome and total and
cardiovascular disease mortality in middle-aged men. Jama, 2002.
288(21): p. 2709-2716.
86. Sattar, N., et al., Metabolic syndrome with and without C-reactive
protein as a predictor of coronary heart disease and diabetes in the West
of Scotland Coronary Prevention Study. Circulation, 2003. 108(4): p.
87. Hong, Y., et al., Metabolic syndrome, its preeminent clusters, incident
coronary heart disease and all‐cause mortality–results of prospective
analysis for the Atherosclerosis Risk in Communities study. Journal of
internal medicine, 2007. 262(1): p. 113-122.
88. Lebovitz, H.E., Type 2 diabetes: an overview. Clinical chemistry, 1999.
45(8): p. 1339-1345.
89. Grundy, S.M., Metabolic syndrome: connecting and reconciling
cardiovascular and diabetes worlds. Journal of the American College of
Cardiology, 2006. 47(6): p. 1093-1100.
90. Ford, E.S., C. Li, and N. Sattar, Metabolic syndrome and incident
diabetes. Diabetes care, 2008. 31(9): p. 1898-1904.
91. Meigs, J.B., et al., Impact of insulin resistance on risk of type 2 diabetes
and cardiovascular disease in people with metabolic syndrome. Diabetes
care, 2007. 30(5): p. 1219-1225.
92. de Vegt, F., et al., Relation of impaired fasting and postload glucose with
incident type 2 diabetes in a Dutch population: The Hoorn Study. Jama,
2001. 285(16): p. 2109-2113.
93. Bloomgarden, Z.T., Second world congress on the insulin resistance
syndrome. Diabetes Care, 2005. 28(7): p. 1821-1830.
94. Kim, H.J., et al., Metabolic significance of nonalcoholic fatty liver
disease in nonobese, nondiabetic adults. Archives of internal medicine,
2004. 164(19): p. 2169-2175.
95. Hamaguchi, M., et al., The metabolic syndrome as a predictor of
nonalcoholic fatty liver disease. Annals of internal medicine, 2005.
143(10): p. 722.
96. Donnelly, K.L., et al., Sources of fatty acids stored in liver and secreted
via lipoproteins in patients with nonalcoholic fatty liver disease. Journal
of Clinical Investigation, 2005. 115(5): p. 1343.
97. Méndez‐Sánchez, N., et al., Current concepts in the pathogenesis of
nonalcoholic fatty liver disease. Liver International, 2007. 27(4): p. 423-433.
98. Masserini, B., et al., Reduced levels of adiponectin in sleep apnea syndrome.
Journal of endocrinological investigation, 2006. 29(8): p. 700-705.
99. Vgontzas, A.N., E.O. Bixler, and G.P. Chrousos, Sleep apnea is a
manifestation of the metabolic syndrome. Sleep medicine reviews, 2005.
9(3): p. 211-224.
100. Chen, R., G. Wittert, and G. Andrews, Relative androgen deficiency in
relation to obesity and metabolic status in older men. Diabetes, Obesity
and Metabolism, 2006. 8(4): p. 429-435.